Drugs control organisation issues guidelines for trial, marketing of vaccines

Drugs control organisation issues guidelines for trial, marketing of vaccines

MTaI Welcomes CDSCO Notice Addressing Challenges And Furthering Ease Of Doing Business For Medical Device Sector

This pace is further slowed because of the several operational bottlenecks which continue to impede smooth functioning of business.

Drug Regulator asks Serum Institute to furnish revised protocol for COVID-19 vaccine clinical trial

Drug Regulator asks Serum Institute to furnish revised protocol for COVID-19 vaccine clinical trial

Top drug regulator CDSCO suspends import license of Mumbai-based firm for its COVID-19 test kit

Top drug regulator CDSCO suspends import license of Mumbai-based firm for its COVID-19 test kit

Bharat Biotech Announces India's First COVID-19 Vaccine Candidate 'COVAXIN' With DCGI Approval For Human Clinical Trials

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' in mild to moderate COVID-19 cases

Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' in mild to moderate COVID-19 cases

Remdesivir included in 'investigational therapy' for restricted emergency use on COVID-19 patients: Health Ministry

Remdesivir included in 'investigational therapy' for restricted emergency use on COVID-19 patients: Health Ministry

Six Indian companies applied to CDSCO for permission to manufacture, market Remdesivir drug: Health Ministry

Six Indian companies applied to CDSCO for permission to manufacture, market Remdesivir drug: Health Ministry

‘We’ve To Be Ready For Scrutiny’

G.N. Singh tells Himani Chandna he is ready to take on even more. He has, in fact, asked the industry how his agency can reduce the regulatory burden to make it easier to do business in India

Will Desi Slogan Put Patients At Risk?

With India’s regulatory mechanism as weak as it is, the latest government advisory could end up being the pass to small-time players to push their subpar products into government hospitals under a competitive price tag

Ban On Anti-Diabetic Drug Likely To Be Lifted

Injecting A Dose Of Ethics

Trial And Horror

India To Probe Alleged Irregularities Within Drug Regulator

Probe Uncovers Serious Problems With India's Drug Regulator